Second Sight Medical Products

$9.11
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.48 (+5.73%) Today
+$0.25 (+2.82%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EYES and other stocks, options, and ETFs commission-free!

About EYES

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It offers Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device intended to provide artificial vision to individuals who are blind due to a wide range of causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury.

CEO
Scott Dunbar
Employees
12
Headquarters
Sylmar, California
Founded
1998
Market Cap
231.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
9.58M
High Today
$10.38
Low Today
$8.07
Open Price
$8.43
Volume
20.52M
52 Week High
$20.00
52 Week Low
$0.6906

EYES Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Jun 28, After Hours

You May Also Like

ASEA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure